Raloxifene as an Adjuvant Therapy for Patients With Schizophrenia: An Up‐To‐Date Systematic Review and Meta‐Analysis
Abstract Background and Hypothesis Raloxifene may be useful as an adjunctive treatment for schizophrenia, particularly in addressing psychotic symptoms. This meta‐analysis aimed to evaluate the effectiveness and safety of adjunctive raloxifene in improving positive, negative, and general psychopatho...
Saved in:
| Main Authors: | Tzu‐Rong Peng, Hung‐Hong Lin, Jian‐Ying Wang, Ming‐Chia Lee, Shih‐Ming Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-07-01
|
| Series: | Brain and Behavior |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/brb3.70649 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01) -
Fabrication of an In Situ pH-Responsive Raloxifene-Loaded Invasome Hydrogel for Breast Cancer Management: In Vitro and In Vivo Evaluation
by: Hanan O. Farouk, et al.
Published: (2024-11-01) -
Engineered Porous Beta-Cyclodextrin-Loaded Raloxifene Framework with Potential Anticancer Activity: Physicochemical Characterization, Drug Release, and Cytotoxicity Studies
by: Alwattar JK, et al.
Published: (2024-11-01) -
Association of raloxifene and tamoxifen therapy with cognitive performance, odds of mild cognitive impairment, and brain MRI markers of neurodegeneration
by: Firat Kara, et al.
Published: (2023-02-01) -
A Multi-Model Machine Learning Framework for Identifying Raloxifene as a Novel RNA Polymerase Inhibitor from FDA-Approved Drugs
by: Nhung Thi Hong Van, et al.
Published: (2025-04-01)